News
Stocktwits on MSN43m
Amylyx Pharma Gains Retail Buzz As Once-Daily Pill Cuts Severe Blood Sugar Crashes In Mid-Stage TrialAmylyx Pharmaceuticals drew increased retail attention late Sunday after new clinical data presented at ENDO 2025 highlighted the potential of its lead candidate, avexitide, to significantly reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback